The global erythroid maturation agent market is experiencing a transformative phase, driven by the emergence of first-in-class biologics that address long-standing gaps in the treatment of chronic blood disorders. Unlike traditional erythropoietin-stimulating agents (ESAs) that stimulate early-stage red blood cell production, these maturation agents target the late stages of erythropo... https://www.databridgemarketresearch.com/reports/global-erythroid-maturation-agent-market